Thermo Fisher Scientific Inc. Website

Thermo Fisher Scientific Inc.

NYSE-TMO

Basic

  • Market Cap

    $209.21B

  • EV

    $237.74B

  • Shares Out

    381.72M

  • Revenue

    $42.49B

  • Employees

    122,000

Margins

  • Gross

    40.37%

  • EBITDA

    25.36%

  • Operating

    17.4%

  • Pre-Tax

    15.33%

  • Net

    14.2%

  • FCF

    17.79%

Returns (5Yr Avg)

  • ROA

    8.19%

  • ROTA

    29.41%

  • ROE

    16.77%

  • ROCE

    11.66%

  • ROIC

    10.79%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $628.2

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $7,250M

  • Net Debt

    $28.41B

  • Debt/Equity

    0.78

  • EBIT/Interest

    5.16

Growth (CAGR)

  • Rev 3Yr

    5.79%

  • Rev 5Yr

    11.52%

  • Rev 10Yr

    11.9%

  • Dil EPS 3Yr

    -7.76%

  • Dil EPS 5Yr

    14.78%

  • Dil EPS 10Yr

    14.72%

  • Rev Fwd 2Yr

    3.64%

  • EBITDA Fwd 2Yr

    4.34%

  • EPS Fwd 2Yr

    6.13%

  • EPS LT Growth Est

    9.36%

Dividends

  • Yield

  • Payout

    9.19%

  • DPS

    $1.44

  • DPS Growth 3Yr

    16.11%

  • DPS Growth 5Yr

    15.52%

  • DPS Growth 10Yr

    9.15%

  • DPS Growth Fwd 2Yr

    7.59%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Total Revenues

25,542

32,218

39,211

44,915

42,857

42,492

Total Revenues % Chg.

4.9%

26.1%

21.7%

14.5%

-4.6%

-3%

Cost of Goods Sold, Total

14,214

16,214

19,573

25,944

25,744

25,340

Gross Profit

11,328

16,004

19,638

18,971

17,113

17,152

Selling General & Admin Expenses, Total

6,139

6,940

7,857

8,940

8,381

8,434

R&D Expenses

1,003

1,181

1,406

1,471

1,337

1,322

Other Operating Expenses

16

3

1

1

Other Operating Expenses, Total

7,142

8,137

9,266

10,411

9,719

9,757

Operating Income

4,186

7,867

10,372

8,560

7,394

7,395

Interest Expense, Total

-676

-553

-536

-726

-1,375

-1,434

Interest And Investment Income

224

65

43

272

879

1,012

Net Interest Expenses

-452

-488

-493

-454

-496

-422

Income (Loss) On Equity Invest.

-3

-4

-172

-59

-11

Currency Exchange Gains (Loss)

162

102

-29

-58

Other Non Operating Income (Expenses)

65

5

-161

-35

5

34

EBT, Excl. Unusual Items

3,799

7,381

9,876

8,001

6,815

6,938

Restructuring Charges

-52

-51

-37

-68

-233

-152

Merger & Related Restructuring Charges

-81

-35

10

Gain (Loss) On Sale Of Investments

44

10

66

-161

-46

8

Gain (Loss) On Sale Of Assets

482

14

Asset Writedown

-32

-122

-60

-219

-219

Legal Settlements

-19

-1

Other Unusual Items

-201

-911

-63

-59

-70

EBT, Incl. Unusual Items

4,072

7,227

8,837

7,663

6,239

6,514

Income Tax Expense

374

850

1,109

703

284

519

Earnings From Continuing Operations

3,698

6,377

7,728

6,960

5,955

5,995

Earnings Of Discontinued Operations

Minority Interest

-2

-2

-3

-10

40

39

Net Income

3,696

6,375

7,725

6,950

5,995

6,034

Net Income to Common Incl Extra Items

3,696

6,375

7,725

6,950

5,995

6,034

Net Income to Common Excl. Extra Items

3,696

6,375

7,725

6,950

5,995

6,034

Total Shares Outstanding

398.7

396.7

394.4

390.5

386.6

381.7

Weighted Avg. Shares Outstanding

400

396

394

392

386

385

Weighted Avg. Shares Outstanding Dil

403

399

397

394

388

387

EPS

9.2

16.1

19.6

17.7

15.5

15.7

EPS Diluted

9.2

16

19.5

17.6

15.5

15.6

EBITDA

6,463

10,192

12,964

11,941

10,800

10,778

Effective Tax Rate

9.2%

11.8%

12.5%

9.2%

4.6%

8%